Gene expression analysis to identify mRNA markers of cardiac myxoma

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 3, 2004, Pages 717-733

  Skamrov, A V ^a   Nechaenko, M A ^b   Goryunova, L E ^a   Feoktistova, E S ^a   Khaspekov, G L ^a   Kovalevsky, D A ^a   Vinnitsky, L I ^b   Sheremeteva, G F ^b   Beabealashvilli, R Sh ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

ANXA3; Array; CALB2; Cardiac myxoma; Expression marker; FMOD; MIA; PLA2G2A; PLTP; SLPI; SOX9; SPP1; TIMP1

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM BINDING PROTEIN; CALRETININ; CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; ENZYME INHIBITOR; FIBROMODULIN; MELANOMA INHIBITORY ACTIVITY PROTEIN; MESSENGER RNA; PHOSPHOLIPASE A2; PHOSPHOLIPID TRANSFER PROTEIN; PROTEIN ANXA3; PROTEIN SPP1; SCLEROPROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE MARKER; FEMALE; GENE EXPRESSION; HEART MYXOMA; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UNINDEXED SEQUENCE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEART NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MYXOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 4444352390     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.06.006     Document Type: Article

References (54)

1. Shapiro L.M. Cardiac tumors: diagnosis and management. Heart. 85:2001;218-222
2. Petrovsky B.V., Konstantinov B.A., Nechaenko M.A. Primary cardiac tumors. Medicine, Moscow, Russia. 1997
3. Yoon D.H., Roberts W.C. Sex distribution in cardiac myxomas. Am J Cardiol. 90:2002;563-565
4. Becker A.E. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatr Cardiol. 21:2000;317-323
5. Stratakis C.A., Kirschner L.S., Carney J.A. Carney complex: diagnosis and management of the complex of spotty skin pigmentation myxomas, endocrine overactivity, and schwannomas. Am J Med Genet. 80:1998;183-185
6. Stratakis C.A., Kirschner L.S., Carney J.A. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 86:2001;4041-4046
7. Carney J.A. Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol. 9:1985;53-55
8. Casey M., Vaughan C.J., He J., Hatcher C.J., Winter J.M., Weremowicz S., et al. Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest. 106:2000;R31-R39
9. Kirschner L.S., Carney J.A., Pack S.D., Taymans S.E., Giatzakis C., Cho Y.S., et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nature Genet. 26:2000;89-92
10. Stratakis C.A. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex). Ann New York Acad Sci. 968:2002;3-21
11. Skamrov A.V., Feoktistova E.S., Khaspekov G.L., Kovalevsky D.A., Goryunova L.E., Beabealashvilli R.S.H., et al. PRKAR1A gene mutations in two patients with Carney complex. Kardiologiia. 43:2003;77-82
12. Ferrans V.J., Roberts W.C. Structural features of cardiac myxomas: histology, histochemistry, and electron microscopy. Hum Pathol. 4:1973;111-146
13. Burke A.P., Virmani R. Cardiac myxomas: a clinicopathologic study. Am J Clin Pathol. 100:1993;671-680
14. Bell D.A., Greco M.A. Cardiac myxoma with chondroid features: a light and electron microscopic study. Hum Pathol. 12:1981;370-374
15. Roberts W.C. Primary and secondary neoplasms of the heart. Am J Cardiol. 80:1997;671-682
16. Gersak B., Mikek M., Smrkolj V., Gabrijelcic T. Results of treatment of 17 patients with heart tumor. Eur J Surg Oncol. 25:1999;302-305
17. Araoz P.A., Mulvagh S.L., Tazelaar H.D., Julsrud P.R., Breen J.F. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 20:2000;1303-1319
18. Grebenc M.L., Rosado-de Christenson M.L., Green C.E., Burke A.P., Galvin J.R. Cardiac myxoma: imaging features in 83 patients. Radiographics. 22:2002;673-689
19. Gilkeson R.C., Chiles C. MR evaluation of cardiac and pericardial malignancy. Magn Reson Imag Clin North Am. 11:2003;173-186
20. Burke A.P., Virmani R. More on cardiac myxomas. New Engl J Med. 335:1996;1462-1464
21. Sambrook J., Fritch E.F., Maniatis T. Molecular Cloning: a laboratory manual. 2nd ed:1989;Cold Spring Harbor Laboratory Press, New York
22. Strutt B., Khalil W., Killinger D. Growth and differentiation of human adipose stromal cells in culture. Jones G.E. Human cell culture protocols. 1996;41-51 Humana Press, New Jersey
23. Su A.I., Cooke M.P., Ching K.A., Hakak Y., Walker J.R., Wiltshire T., et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA. 99:2002;4465-4470
24. Boheler K.R., Volkova M., Morrell C., Garg R., Zhu Y., Margulies K., et al. Sex- and age-dependent human transcriptome variability: implications for chronic heart failure. Proc Natl Acad Sci USA. 100:2003;2754-2759
25. Hwang D.M., Dempsey A.A., Wang R.X., Rezvani M., Barrans J.D., Dai K.S., et al. A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation. 96:1997;4146-4203
26. Steenman M., Chen Y.W., Le Cunff M., Lamirault G., Varro A., Hoffman E., et al. Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomic. 12:2003;97-112
27. Whitney A.R., Diehn M., Popper S.J., Alizadeh A.A., Boldrick J.C., Relman D.A., et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA. 100:2003;1896-1901
28. Govoni E., Severi B., Cenacchi G., Laschi R., Pileri S., Rivano M.T., et al. Ultrastructural and immunohistochemical contribution to the histogenesis of human cardiac myxoma. Ultrastruct Pathol. 12:1988;221-233
29. Berrutti L., Silverman J.S. Cardiac myxoma is rich in factor XIIIa positive dendrophages: immunohistochemical study of four cases. Histopathology. 28:1996;529-535
30. Farrell D.J., Bulmer E., Angus B., Ashcroft T. Immunohistochemical expression of endothelial markers in left atrial myxomas: a study of six cases. Histopathology. 28:1996;147-152
31. Pucci A., Gagliardotto P., Zanini C., Pansini S., di Summa M., Mollo F. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J. 140:2000;134-138
32. Terracciano L.M., Mhawech P., Suess K., D'Armiento M., Lehmann F.S., Jundt G., et al. Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol. 114:2000;754-759
33. Acebo E., Val-Bernal J.F., Gomez-Roman J.J. Prichard's structures of the fossa ovalis are not histogenetically related to cardiac myxoma. Histopathology. 39:2001;529-535
34. Zhang T., Koide N., Wada Y., Tsukioka K., Takayama K., Kono T., et al. Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma. Circ J. 67:2003;54-60
35. Ishizaki J., Suzuki N., Higashino K., Yokota Y., Ono T., Kawamoto K., et al. Cloning and characterization of novel mouse and human secretory phospholipase A(2)s. J Biol Chem. 274:1999;24973-24979
36. Valentin E., Singer A.G., Ghomashchi F., Lazdunski M., Gelb M.H., Lambeau G. Cloning and recombinant expression of human group IIF-secreted phospholipase A(2). Biochem Biophys Res Commun. 279:2000;223-238
37. Nyman K.M., Ojala P., Laine V.J., Nevalainen T.J. Distribution of group II phospholipase A2 protein and mRNA in rat tissues. J Histochem Cytochem. 48:2000;1469-1478
38. Andreani M., Olivier J.L., Berenbaum F., Raymondjean M., Bereziat G. Transcriptional regulation of inflammatory secreted phospholipases A(2). Biochim Biophys Acta. 1488:2000;149-158
39. Nevalainen T.J., Haapamaki M.M., Gronroos J.M. Roles of secretory phospholipases A(2) in inflammatory diseases and trauma. Biochim Biophys Acta. 1488:2000;83-90
40. Capper E.A., Marshall L.A. Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis. Prog Lipid Res. 40:2001;167-197
41. Dietz U.H., Sandell L.J. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem. 271:1996;3311-3316
42. Bosserhoff A.K., Buettner R. Expression, function and clinical relevance of MIA (melanoma inhibitory activity). Histol Histopathol. 17:2002;289-300
43. Billing-Marczak K., Kuznicki J. Calretinin - sensor or buffer - function still unclear. Pol J Pharmacol. 51:1999;173-178
44. Gerke V., Moss S.E. Annexins: from structure to function. Physiol Rev. 82:2002;331-371
45. Huuskonen J., Ehnholm C. Phospholipid transfer protein in lipid metabolism. Curr Opin Lipidol. 11:2000;285-289
46. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 92:2003;827-839
47. Hiemstra P.S. Novel roles of protease inhibitors in infection and inflammation. Biochem Soc Trans. 30:2002;116-120
48. McKee M.D., Nanci A. Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res. 35:1996;197-205
49. Chakravarti S. Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconj J. 19:2002;287-293
50. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox9 is required for cartilage formation. Nat Genet. 22:1999;85-89
51. Schwaller B., Meyer M., Schiffmann S. "New" functions for "old" proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum. 1:2002;241-258
52. Leung S.Y., Chen X., Chu K.M., Yuen S.T., Mathy J., Ji J., et al. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci USA. 99:2002;16203-16208
53. de Crombrugghe B., Lefebvre V., Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol. 13:2001;721-727
54. Pullig O., Weseloh G., Gauer S., Swoboda B. Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol. 19:2000;245-255